Keywords: allergan, data, inadequate, presented, ocufen, flurbiprofen, do

ALLERGAN DATA INADEQUATE

Article | 09 November 1992

Print This

- The data presented by Allergan for Ocufen (flurbiprofen) do not support a new indication for postoperative cystoid macular edema without ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in